144
Participants
Start Date
January 31, 2004
Primary Completion Date
December 31, 2006
Study Completion Date
December 31, 2006
Visilizumab
Weill Medical College of Cornell, New York
Mount Sinai School of Medicine, New York
University of Pittsburgh Medical Center, Pittsburgh
UPHS/Presbyterian Medical Center, Philadelphia
Atlanta Gastroenterology Associates, Atlanta
Mayo Clinic Rochester, Rochester
Northwestern University, Chicago
University of Chicago Medical Center, Chicago
University of Texas Medical Branch, Galveston
Inflammatory Bowel Disease Center, Los Angeles
University of California, San Francisco, San Francisco
Lead Sponsor
Collaborators (1)
PDL BioPharma, Inc.
INDUSTRY
Facet Biotech
INDUSTRY